Neurocentrx names new non-executive chairman
16 April 2018 -

Neurocentrx, a United Kingdom-based pharmaceutical company, has named Nigel Brooksby as its non-executive chairman, it was reported on Friday.

Brooksby has experience in business and growth strategy across the healthcare sector having held senior global positions at Pfizer, Sanofi and Wellcome and now GSK. His career history has seen him work in private equity and venture capital and he has been president of the ABPI.

Brooksby said, 'My focus is to accelerate the business model and drive commercial clinical trials to raise international awareness of what we are offering, and enter the global market. I look forward to working the team, and helping to drive the company to an exciting new stage in their development.'